Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores

BACKGROUND: The recommendation for chemotherapy in early-stage breast cancer patients has been refined by the 21-gene Recurrence Score. However, uncertainty remains whether patients in the Intermediate Risk category benefit from chemotherapy. METHODS: We analyzed female patients from the National Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jonathan, Wu, Xian, Christos, Paul J., Formenti, Silvia, Nagar, Himanshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903005/
https://www.ncbi.nlm.nih.gov/pubmed/29661221
http://dx.doi.org/10.1186/s13058-018-0957-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903005/
https://www.ncbi.nlm.nih.gov/pubmed/29661221
http://dx.doi.org/10.1186/s13058-018-0957-3

Ejemplares similares